| Pharmaceutical active ingredients: |
| Metronidazole |
| Available forms, composition and doses of Flagemona: |
| N / A |
| Flagemona medical category: |
| Human:AntiamoebicsAntibioticsAntiprotozoal agentsAntiseptic skin cleansersLocal anti-infectivesPreparations for vaginal conditionsTopical chemotherapeutics used in the treatment of dermatological diseases |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A01AB17 - MetronidazoleD06BX01 - MetronidazoleG01AF01 - MetronidazoleJ01XD01 - MetronidazoleP01AB01 - Metronidazole |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Fivent | Cromolyn | Unidentified Pharmaceutical Company |
| Fixanol C | Cetylpyridinium | Unidentified Pharmaceutical Company |
| Fixol | Hydroxycitronellal | Unidentified Pharmaceutical Company |
| Flacedil | Gallamine Triethiodide | Unidentified Pharmaceutical Company |
| Flacethyle | Efloxate | Unidentified Pharmaceutical Company |
| Flagesol | Metronidazole | Unidentified Pharmaceutical Company |
| Flaianina | Diiodotyrosine | Unidentified Pharmaceutical Company |
| Flair | Malathion | Unidentified Pharmaceutical Company |
| Flamasone | Prednisolone | Unidentified Pharmaceutical Company |
| Flambate | Nabumetone | Unidentified Pharmaceutical Company |